Neuropsychiatrische Post-COVID-Symptome

Abstract

1. World Health Organization. COVID-19 Weekly Epidemiological Update Edition 45, published 22 June 2021. https://www.who.int/ publications/m/item/weekly-epidemiological-update-on-covid19---22-june-2021 (last accessed on 24 June 2021) 2. van Kampen JJA, van de Vijver DAMC, Fraaij PLA et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun 2021;12:267. doi: 10.1038/s41467-020-20568-4. PMID: 33431879; PMCID: PMC7801729 3. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ 2021;372:n136. doi: 10.1136/bmj.n136. PMID: 33483331 4. Marshall M. The four most urgent questions about long COVID. Nature2021;594:168-170. doi: 10.1038/d41586-021-01511-z. PMID: 34108700 5. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/ Steckbrief.html;jsessionid=8C227D64D190DCD921EB458A19982676.inte rnet071?nn=13490888#doc13776792bodyText9 (last accessed on 24 June 2021) 6. Lopez-Leon S, Wegman-Ostrosky T, Perelman C et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Preprint. medRxiv. 2021;2021.01.27.21250617. doi:10.1101/2021.01.27.2125 0617 7. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021. doi: 10.1038/s41586-021-03553-9. Epub ahead of print. PMID: 33887749 8. Sudre CH, Murray B, Varsavsky T et al. Attributes and predictors of long COVID. Nat Med 2021;27:626-31. doi: 10.1038/s41591-021-01292-y. Epub 2021 Mar 10. Erratum in: Nat Med 2021;27:1116. PMID: 33692530 9. Nalbandian A, Sehgal K, Gupta A et al. Post-acute COVID-19 syndrome. Nat Med 2021;27:601-15. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22. PMID: 33753937 10. Townsend L, Dowds J, O‘Brien K et al. Persistent Poor Health after COVID-19 Is Not Associated with Respiratory Complications or Initial Disease Severity. Ann Am Thorac Soc 2021;18:997-1003. doi: 10.1513/ AnnalsATS.202009-1175OC. PMID: 33413026 11. Gupta A, Madhavan MV, Sehgal K et al. Extrapulmonary manifestations of COVID-19. Nat Med 2020;26:1017-32. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10. PMID: 32651579 12. Halpin SJ, McIvor C, Whyatt G et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021;93:1013-1022. doi: 10.1002/jmv.26368. Epub 2020 Aug 17. PMID: 32729939 13. Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry 2021;8:13040. doi: 10.1016/S2215-0366(20)30462-4. Epub 2020 Nov 9. Erratum in: Lancet Psychiatry 2021;8:e1. PMID: 33181098; PMCID: PMC7820108 14. Rogers JP, Chesney E, Oliver D et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 2020;7:611-27. doi: 10.1016/ S2215-0366(20)30203-0. Epub 2020 May 18. PMID: 32437679; PMCID: PMC7234781 15. Neufeld KJ, Leoutsakos JS, Yan H et al. Fatigue symptoms during the first year following ARDS. Chest 2020;158:999-1007. doi: 10.1016/j. chest.2020.03.059. Epub 2020 Apr 15. PMID: 32304774; PMCID: PMC7478232 16. Bacaro V, Chiabudini M, Buonanno C et al. Insomnia in the italian population during Covid-19 outbreak: A snapshot on one major risk factor for depression and anxiety. Front Psychiatry 2020;11:579107. doi:10.3389/ fpsyt.2020.579107 17. Kaseda ET, Levine AJ. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol 2020;34:1498-514. doi: 10.1080/13854046.2020.1811894. EPMID: 32847484 18. Miskowiak KW, Johnsen S, Sattler SM, Nielsen S, Kunalan K, Rungby J, Lapperre T, Porsberg CM. Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol 2021;46:39-48. doi: 10.1016/j.euroneuro.2021.03.019. PMID: 33823427; PMCID: PMC8006192 19. Chu H, Chan JF, Yuen TT et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe 2020;1:e14-e23. doi: 10.1016/S2666-5247(20)30004-5. Epub 2020 Apr 21. PMID: 32835326; PMCID: PMC7173822 20. Guedj E, Campion JY, Dudouet P et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging 2021. doi: 10.1007/s00259-021-05215-4. PMID: 33501506; PMCID: PMC7837643 21. Hosp JA, Dressing A, Blazhenets G et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain 2021;144:1263-76. doi: 10.1093/brain/awab009. PMID: 33822001; PMCID: PMC8083602 22. Blazhenets G, Schröter N, Bormann T et al. Slow but evident recovery from neocortical dysfunction and cognitive impairment in a series of chronic COVID-19 patients. J Nucl Med 2021:jnumed.121.262128. doi: 10.2967/jnumed.121.262128. Epub ahead of print. PMID: 33789937 zertifizierte fortbildung